Your browser doesn't support javascript.
loading
Microbial pathogenicity: a new approach to drug development.
Chakrabarty, Ananda M.
Afiliação
  • Chakrabarty AM; Department of Microbiology and Immunology, University of Illinois College of Medicine, 835 South Wolcott Avenue, Chicago, IL, 60612, USA, pseudomo@uic.edu.
Adv Exp Med Biol ; 808: 41-9, 2014.
Article em En | MEDLINE | ID: mdl-24595609
ABSTRACT
Pathogenic microorganisms, particularly pathogenic bacteria that cause debilitating diseases, are considered a threat for human health and well-being. Infectious diseases are rampant, particularly in developing countries. However, there are many other deadly diseases, such as cancer, diabetes, cardiac malfunction, etc., that account for significant loss of life and trauma in our society. In this article, I try to describe the role certain bacterial pathogens with long term residence in the human body can play in providing us with our next generation anticancer and other drugs, demonstrating that a certain amount of good can come out of such bacterial pathogens as well.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Pseudomonas aeruginosa / Azurina / Neoplasias da Mama / Antineoplásicos Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Pseudomonas aeruginosa / Azurina / Neoplasias da Mama / Antineoplásicos Idioma: En Ano de publicação: 2014 Tipo de documento: Article